Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Neuroendocrine Cancer Headlining the News

OCTOBER 2024 19/10//2024 'Doctors put my symptoms down to allergy - now I've got incurable cancer' It took four years for a cancer sufferer to get treatment for his very rare disease and by the time he did it had become incurable and inoperable. Saying he was going to...

read more

PERT Update

As some of you may be aware, we are working with fellow charities and patient organisations to ‘lobby’ and work with the government and other stakeholders to better address PERT shortages. Our working group of charities and patient organisations meets monthly, and...

read more